Structural Heart Market Forecast to 2028 - Global Analysis By Product, Procedure, and End User

Description

List of Tables

The structural heart market was valued at US$ 14,245.55 million in 2022 and is expected to reach US$ 22,560.88 million by 2028; it is estimated to record a CAGR of 8.0% from 2022 to 2028. The structural heart market growth is attributed to the availability of innovative structural heart services and a rise in the number of cardiovascular procedures and corresponding training programs.

Structural heart disease is a non-coronary defect of the heart, thus not affecting the blood vessels in the heart. Most structural heart conditions are present since birth (congenital), but these can also be acquired later in life owing to wear & tear from infection. The devices that are used in structural heart disease comprise replacement and repair devices, such as devices that are used for the treatment of heart-related diseases. Structural heart devices comprise annuloplasty rings and heart valve balloons occluders, among others.

Growing Use of Artificial Intelligence in Structural Heart Provides Lucrative Opportunities for Structural Heart Market During Forecast Period

The number of interventional structural heart disease (SHD) procedures, such as transcatheter valve procedures, has increased significantly in recent years, triggering the need for well-founded knowledge about optimal anatomical spatial orientation during these procedures. This has led to the development of new procedural capabilities and technologies in periprocedural planning. Ongoing developments in machine learning and artificial intelligence (AI) facilitate the routine use of individualized segmented 3D heart models that allow to use multiple imaging modalities in combination with other. As AI enables computers to perform tasks at a greater speed and with potentially better precision than humans, risk stratification and outcome aspects can be optimized in the future. The application of computer modeling, 3D printing, and AI has already led to transformations in procedure planning and physician education on SHD. These technologies also promise unlimited possibilities. With further research and development, AI can advance precision medicine at every step, including diagnosis, treatment stratification and device selection, procedure delivery and guidance, and post-procedure/discharge monitoring and rehabilitation, and create ample opportunities in the structural heart market.

The structural heart is a rapidly evolving branch of cardiology, and North American, European, and other developing countries are experiencing advancements in related technologies. The prevalence of cardiovascular diseases is rising in these countries. The structural heart market is at the initial stage of development in regions such as Asia Pacific, the Middle East, and Africa. For instance, in India, KIMS Hospital provides services for the structural heart in South India. Most of the people in South India chew or smoke tobacco; as a result, the incidence of structural heart disease is increasing in this region. According to the American Heart, cardiovascular diseases caused ~19.1 million deaths worldwide in 2020. In 2020, Eastern Europe and Central Asia had the highest cardiovascular mortality rates. Oceania, North Africa, the Middle East, Central Europe, Sub-Saharan Africa, and South and Southeast Asia also reported higher mortality rates. Thus, with the rising incidence of structural heart diseases in the abovementioned regions, the market players are likely to create significant opportunities to offer effective products in the structural heart market in the coming years.

Structural Heart Market, By Procedure-Based Insights

Based on procedure, the structural heart market is segmented into aortic valve stenosis, aortic valve regurgitation, and left atrial appendage closure. In 2022, the aortic valve stenosis segment held the largest share of the structural heart market. However, the left atrial appendage closure segment is anticipated to register the highest CAGR during the forecast period. The aortic valve stenosis segment is further segmented into balloon valvuloplasty, aortic valve replacement, transcatheter aortic valve replacement (TAVR), aortic valve repair, and mitral valve repair and replacement. The aortic valve repair subsegment of structural heart market held the largest market share in 2022; however, the aortic valve replacement subsegment is anticipated to register the highest CAGR during the forecast period. The aortic valve regurgitation is further segmented into mitral valve repair and replacement, aortic valve repair, transcatheter aortic valve replacement (TAVR), and aortic valve replacement.

Transcatheter aortic valve replacement is one of the advanced minimally invasive procedures for the treatment of aortic stenosis, which is gaining popularity in developing economies. The key players launched new products and accessories to simplify the overall procedures. For instance, in 2022, Abbott launched Navitor, its latest-generation transcatheter aortic valve implantation (TAVI) system, making the minimally invasive device available for people in India with severe aortic stenosis at high or extreme surgical risk. Additionally, there has been an increase in the number of training programs and conferences on a global level for such procedures, which is likely to contribute to the growth structural heart market in the coming years.

The World Health Organization (WHO), Society for Cardiovascular Angiography and Interventions, Center for Device and Radiological Health, Center for Disease Control and Prevention, American Board of International Medicine, and American College of Cardiology are among the primary and secondary sources referred to while preparing the report on the structural heart market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the structural heart market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global structural heart market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution

Product Code: TIPHE100001164

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Structural Heart Market - by Product
- 1.3.2 Global Structural Heart Market - by Procedure
- 1.3.3 Global Structural Heart Market - by End User
- 1.3.4 Global Structural Heart Market - by Geography

2. Structural Heart Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Structural Heart Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East & Africa PEST Analysis
- 4.2.5 South & Central America PEST Analysis
4.3 Expert's Opinion

5. Structural Heart Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Availability of Innovative Structural Heart Services
- 5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
5.2 Key Market Restraints
- 5.2.1 High Cost of Procedures
- 5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Key Market Opportunities
- 5.3.1 Growing Use of Artificial Intelligence in Structural Heart
5.4 Future Trends
- 5.4.1 Technological Advancements in the Field of Structural Heart Devices
5.5 Impact analysis

6. Structural Heart Market - Global Analysis

6.1 Global Structural Heart Market Revenue Forecast and Analysis
6.2 Global Structural Heart Market, by Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Top Market Players
- 6.4.1 Abbott Laboratories
- 6.4.2 Medtronic Plc
- 6.4.3 Edwards Lifesciences

7. Global Structural Heart Market - Revenue and Forecast to 2028 - by Product

7.1 Overview
7.2 Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Occluders
- 7.3.1 Overview
- 7.3.2 Occluders: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Annuloplasty Rings
- 7.4.1 Overview
- 7.4.2 Annuloplasty Rings: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Heart Valve Balloons
- 7.5.1 Overview
- 7.5.2 Heart Valve Balloons: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

8. Global Structural Heart Market - Revenue and Forecast to 2028 - by Procedure

8.1 Overview
8.2 Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
8.3 Heart Valve Stenosis
- 8.3.1 Overview
- 8.3.2 Heart Valve Stenosis: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Heart Valve Regurgitation
- 8.4.1 Overview
- 8.4.2 Heart Valve Regurgitation: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Left Atrial Appendage Closure
- 8.5.1 Overview
- 8.5.2 Left Atrial Appendage Closure: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

9. Global Structural Heart Market - Revenue and Forecast to 2028 - by End User

9.1 Overview
9.2 Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiac Centers
- 9.5.1 Overview
- 9.5.2 Cardiac Centers: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

10. Structural Heart Market - Revenue and Forecast to 2028 - Geographic Analysis

10.1 North America: Structural Heart Market
- 10.1.1 Overview
- 10.1.2 North America: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.3 North America: Structural Heart Market, by Product, 2019-2028 (US$ Million)
- 10.1.4 North America: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
  - 10.1.4.1 North America: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
  - 10.1.4.2 North America: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
- 10.1.5 North America: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.1.5.1 United States: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.5.1.1 Overview
    - 10.1.5.1.2 United States: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.5.1.3 United States: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.1.5.1.4 United States: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.1.5.1.4.1 United States: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.1.5.1.4.2 United States: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.1.5.1.5 United States: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.1.5.2 Canada: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.5.2.1 Overview
    - 10.1.5.2.2 Canada: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.5.2.3 Canada: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.1.5.2.4 Canada: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.1.5.2.4.1 Canada: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.1.5.2.4.2 Canada: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.1.5.2.5 Canada: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.1.5.3 Mexico: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.5.3.1 Overview
    - 10.1.5.3.2 Mexico: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.5.3.3 Mexico: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.1.5.3.4 Mexico: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.1.5.3.4.1 Mexico: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.1.5.3.4.2 Mexico: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.1.5.3.5 Mexico: Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.2 Europe: Structural Heart Market
- 10.2.1 Overview
- 10.2.2 Europe: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 10.2.3 Europe: Structural Heart Market, by Product, 2019-2028 (US$ Million)
- 10.2.4 Europe: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
  - 10.2.4.1 Europe: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
  - 10.2.4.2 Europe: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
- 10.2.5 Europe: Structural Heart Market, by End User, 2019-2028 (US$ Million)
- 10.2.6 Europe: Structural Heart Market, by Country, 2021 & 2028 (%)
  - 10.2.6.1 Germany: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.1 Overview
    - 10.2.6.1.2 Germany: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.3 Germany: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.2.6.1.4 Germany: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.2.6.1.4.1 Germany: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.2.6.1.4.2 Germany: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.2.6.1.5 Germany: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.2.6.2 UK: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.1 Overview
    - 10.2.6.2.2 UK: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.3 UK: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.2.6.2.4 UK: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.2.6.2.4.1 UK: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.2.6.2.4.2 UK: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.2.6.2.5 UK: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.2.6.3 France: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.1 Overview
    - 10.2.6.3.2 France: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.3 France: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.2.6.3.4 France: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.2.6.3.4.1 France: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.2.6.3.4.2 France: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.2.6.3.5 France: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.2.6.4 Italy: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.1 Overview
    - 10.2.6.4.2 Italy: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.3 Italy: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.2.6.4.4 Italy: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.2.6.4.4.1 Italy: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.2.6.4.4.2 Italy: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.2.6.4.5 Italy: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.2.6.5 Spain: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.1 Overview
    - 10.2.6.5.2 Spain: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.3 Spain: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.2.6.5.4 Spain: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.2.6.5.4.1 Spain: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.2.6.5.4.2 Spain: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.2.6.5.5 Spain: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.2.6.6 Rest of Europe: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.1 Overview
    - 10.2.6.6.2 Rest of Europe: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.3 Rest of Europe: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.2.6.6.4 Rest of Europe: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.2.6.6.4.1 Rest of Europe: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.2.6.6.4.2 Rest of Europe: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.2.6.6.5 Rest of Europe: Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.3 Asia Pacific: Structural Heart Market
- 10.3.1 Overview
- 10.3.2 Asia Pacific: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 10.3.3 Asia Pacific: Structural Heart Market, by Product, 2019-2028 (US$ Million)
- 10.3.4 Asia Pacific: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
- 10.3.5 Asia Pacific: Structural Heart Market, by End User, 2019-2028 (US$ Million)
- 10.3.6 Asia Pacific: Structural Heart Market, by Country, 2021 & 2028 (%)
  - 10.3.6.1 China: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.1.1 Overview
    - 10.3.6.1.2 China: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.1.3 China: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.3.6.1.4 China: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.3.6.1.4.1 China: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.3.6.1.4.2 China: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.3.6.1.5 China: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.3.6.2 Japan: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.2.1 Overview
    - 10.3.6.2.2 Japan: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.2.3 Japan: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.3.6.2.4 Japan: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.3.6.2.4.1 Japan: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.3.6.2.4.2 Japan: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.3.6.2.5 Japan: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.3.6.3 India: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.3.1 Overview
    - 10.3.6.3.2 India: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.3.3 India: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.3.6.3.4 India: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.3.6.3.4.1 India: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.3.6.3.4.2 India: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.3.6.3.5 India: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.3.6.4 Australia: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.4.1 Overview
    - 10.3.6.4.2 Australia: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.4.3 Australia: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.3.6.4.4 Australia: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.3.6.4.4.1 Australia: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.3.6.4.4.2 Australia: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.3.6.4.5 Australia: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.3.6.5 South Korea: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.5.1 Overview
    - 10.3.6.5.2 South Korea: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.5.3 South Korea: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.3.6.5.4 South Korea: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.3.6.5.4.1 South Korea: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.3.6.5.4.2 South Korea: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.3.6.5.5 South Korea: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.3.6.6 Rest of Asia Pacific: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.6.1 Overview
    - 10.3.6.6.2 Rest of Asia Pacific: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.6.3 Rest of Asia Pacific: Structural Heart Market, by Product, 2019-2028 (US$ Million)
    - 10.3.6.6.4 Rest of Asia Pacific: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
    - 10.3.6.6.4.1 Rest of Asia Pacific: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.3.6.6.4.2 Rest of Asia Pacific: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.3.6.6.5 Rest of Asia Pacific: Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.4 Middle East & Africa Structural Heart Market
- 10.4.1 Overview
- 10.4.2 Middle East & Africa: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 10.4.3 Middle East & Africa: Structural Heart Market, by Product, 2019-2028 (US$ Million)
- 10.4.4 Middle East & Africa: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
  - 10.4.4.1 Middle East & Africa: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
  - 10.4.4.2 Middle East & Africa: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
- 10.4.5 Middle East & Africa: Structural Heart Market, by End User, 2019-2028 (US$ Million)
  - 10.4.5.1 Saudi Arabia: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.5.1.1 Overview
    - 10.4.5.1.2 Saudi Arabia: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.5.1.3 Saudi Arabia: Structural Heart Market, by Product, 2019-2028 (USD Million)
    - 10.4.5.1.4 Saudi Arabia: Structural Heart Market, by Procedure, 2019-2028 (USD Million)
    - 10.4.5.1.4.1 Saudi Arabia: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
    - 10.4.5.1.4.2 Saudi Arabia: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
    - 10.4.5.1.5 Saudi Arabia: Structural Heart Market, by End User, 2019-2028 (USD Million)
  - 10.4.5.2 UAE: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.5.2.1 Overview
    - 10.4.5.2.2 UAE: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.5.2.3 UAE: Structural Heart Market, by Product, 2019-2028 (USD Million)
    - 10.4.5.2.4 UAE: Structural Heart Market, by Procedure, 2019-2028 (USD Million)
    - 10.4.5.2.4.1 UAE: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
    - 10.4.5.2.4.2 UAE: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
    - 10.4.5.2.5 UAE: Structural Heart Market, by End User, 2019-2028 (USD Million)
  - 10.4.5.3 South Africa: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.5.3.1 Overview
    - 10.4.5.3.2 South Africa: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.5.3.3 South Africa: Structural Heart Market, by Product, 2019-2028 (USD Million)
    - 10.4.5.3.4 South Africa: Structural Heart Market, by Procedure, 2019-2028 (USD Million)
    - 10.4.5.3.4.1 South Africa: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
    - 10.4.5.3.4.2 South Africa: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
    - 10.4.5.3.5 South Africa: Structural Heart Market, by End User, 2019-2028 (USD Million)
  - 10.4.5.4 Rest of Middle East & Africa: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.5.4.1 Overview
    - 10.4.5.4.2 Rest of Middle East & Africa: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.5.4.3 Rest of Middle East & Africa: Structural Heart Market, by Product, 2019-2028 (USD Million)
    - 10.4.5.4.4 Rest of Middle East & Africa: Structural Heart Market, by Procedure, 2019-2028 (USD Million)
    - 10.4.5.4.4.1 Rest of Middle East & Africa: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
    - 10.4.5.4.4.2 Rest of Middle East & Africa: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
    - 10.4.5.4.5 Rest of Middle East & Africa: Structural Heart Market, by End User, 2019-2028 (USD Million)
10.5 South & Central America Structural Heart Market
- 10.5.1 Overview
- 10.5.2 South & Central America: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 10.5.3 South & Central America: Structural Heart Market, by Product, 2019-2028 (US$ Million)
- 10.5.4 South & Central America: Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
  - 10.5.4.1 South & Central America: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
  - 10.5.4.2 South & Central America: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
- 10.5.5 South & Central America: Structural Heart Market, by End User, 2019-2028 (US$ Million)
- 10.5.6 South & Central America: Structural Heart Market, by Country, 2021 & 2028 (%)
  - 10.5.6.1 Brazil: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.1.1 Overview
    - 10.5.6.1.2 Brazil: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.1.3 Brazil: Structural Heart Market, by Product, 2019-2028 (USD Million)
    - 10.5.6.1.4 Brazil: Structural Heart Market, by Procedure, 2019-2028 (USD Million)
    - 10.5.6.1.4.1 Brazil: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
    - 10.5.6.1.4.2 Brazil: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
    - 10.5.6.1.5 Brazil: Structural Heart Market, by End User, 2019-2028 (USD Million)
  - 10.5.6.2 Argentina: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.2.1 Overview
    - 10.5.6.2.2 Argentina: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.2.3 Argentina: Structural Heart Market, by Product, 2019-2028 (USD Million)
    - 10.5.6.2.4 Argentina: Structural Heart Market, by Procedure, 2019-2028 (USD Million)
    - 10.5.6.2.4.1 Argentina: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
    - 10.5.6.2.4.2 Argentina: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
    - 10.5.6.2.5 Argentina: Structural Heart Market, by End User, 2019-2028 (USD Million)
  - 10.5.6.3 Rest of South & Central America: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.3.1 Overview
    - 10.5.6.3.2 Rest of South & Central America: Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.3.3 Rest of South & Central America: Structural Heart Market, by Product, 2019-2028 (USD Million)
    - 10.5.6.3.4 Rest of South & Central America: Structural Heart Market, by Procedure, 2019-2028 (USD Million)
    - 10.5.6.3.4.1 Rest of South & Central America: Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
    - 10.5.6.3.4.2 Rest of South & Central America: Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
    - 10.5.6.3.5 Rest of South & Central America: Structural Heart Market, by End User, 2019-2028 (USD Million)

11. Impact of COVID-19 Pandemic on Structural Heart Market

11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Global Structural Heart Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies
- 12.2.1 Overview

13. Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Medtronic Plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Boston Scientific Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Artivion Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Edwards Lifesciences Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Lepu Medical Technology Beijing Co Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Braile Biomedica Industry, Commerce and Representations Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Aran Biomedical Teoranta
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Micro Interventional Devices Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Corcym UK Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms